In JDM patients with anti-TIF1-γ and anti-MDA5 antibodies, a decreased capacity for the degradation of NETs was observed and the NETs remnants in peripheral blood correlated with the serum levels of IL-8 and immune complexes (56). Here, TRIM33 is linked to juvenile dermatomyositis.